Isomorphic raises $5 billion, partners with Merck
Isomorphic Labs Ltd has raised $5 billion in a Series C financing and expanded its pharma network under a new partnership with Merck & Co Inc. The financing was disclosed on 17 November and followed two days later by an announcement from Merck. The US company said the new research collaboration is aimed at identifying prospective small molecule candidates targeting “an oncology target of strategic importance.”